~~<i id='2ACBFADD71'><strike id='2ACBFADD71'><tt id='2ACBFADD71'><pre id='2ACBFADD71'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：entertainment 2025-10-06 16:50:16 Page View：3477

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Florida health officials providing scant details on measles cases
Next article： Walensky prepares to leave CDC — and Congress — behind

Wikipedia

Sports medicine is finally prioritizing gender equality

MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

The White House hikes tariffs on plastic syringes made in China

Inadditiontomedicaldevices,theUnitedStateswillraisetariffson$18billionworthofproductsincludingelectr

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

STAT reporters are Pulitzer Prize finalists for investigative reporting

STATDearReaders,WeareenormouslyproudthatSTATreportersCaseyRossandBobHermanhavebeennamedfinalistsfort